Recovery of Endocrine Function After Islet and Pancreas Transplantation
- 5 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Diabetes Reports
- Vol. 12 (5), 587-596
- https://doi.org/10.1007/s11892-012-0294-3
Abstract
Long-standing type 1 diabetes (T1D) is associated with an absolute loss of endogenous insulin secretion (circulating C-peptide is undetectable) and a related defect in glucose counter-regulation that is often complicated by hypoglycemia unawareness, markedly increasing the risk for severe hypoglycemia. Both the transplantation of isolated islets and a whole pancreas can restore β-cell secretory capacity, improve glucose counter-regulation, and return hypoglycemia awareness, thus alleviating severe hypoglycemia. The transplantation of islets may require more than one donor pancreas, and the recovery of endocrine function for now appears more durable with a whole pancreas; however, islet transplantation outcomes are steadily improving. Because not all patients with T1D experiencing severe hypoglycemia are candidates to receive a whole pancreas, and since not all pancreata are technically suitable for whole organ transplantation, islet and pancreas transplantation are evolving as complementary approaches for the recovery of endocrine function in patients with the most problematic T1D.Keywords
This publication has 114 references indexed in Scilit:
- Metabolic Function of a Suboptimal Transplanted Islet Mass in Nonhuman Primates on Rapamycin MonotherapyCell Transplantation, 2012
- Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 DiabetesAmerican Journal of Transplantation, 2012
- Accumulation of Intrahepatic Islet Amyloid in a Nonhuman Primate Transplant ModelEndocrinology, 2012
- Islet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary?Current Diabetes Reports, 2010
- Insulin Reciprocally Regulates Glucagon Secretion in HumansDiabetes, 2010
- β-Cell Secretory Capacity and Demand in Recipients of Islet, Pancreas, and Kidney TransplantsJournal of Clinical Endocrinology & Metabolism, 2010
- Effect of Glucagon-Like Peptide-1 on β- and α-Cell Function in Isolated Islet and Whole Pancreas Transplant RecipientsJournal of Clinical Endocrinology & Metabolism, 2009
- Long-Term Insulin Independence and Improvement in Insulin Secretion After Supplemental Islet Infusion Under Exenatide and EtanerceptTransplantation, 2008
- The Use of Exenatide in Islet Transplant Recipients with Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic EffectsTransplantation, 2008
- Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graftProceedings of the National Academy of Sciences of the United States of America, 2006